Codexis Inc. said Tuesday it has signed a three-year extension on a collaboration agreement with Merck & Co. Inc.
The deal is related to Codexis' catalyst and process development of enzymes used in pharmaceutical manufacturing. The collaboration is in its sixth year.
No comments:
Post a Comment